News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Change in substantial holding

2018 Announcements

01.05.2018

CLINUVEL TO TAKE 100% OWNERSHIP OF VALLAURIX

2018 Announcements

01.05.2018

Appendix 4C

2018 Announcements

30.04.2018

CLINUVEL Newsletter – March 2018

2018 Announcements

26.03.2018

CLINUVEL HOLDS EUROPEAN ERYTHROPOIETIC PROTOPORPHYRIA (EPP) EXPERT MEETING

2018 Announcements

19.03.2018

CLINUVEL sustains profitability first-half of year

2018 Announcements

21.02.2018

CLINUVEL unveils new global positioning

2018 Announcements

13.02.2018

CLINUVEL Newsletter – February 2018

2018 Announcements

12.02.2018

Appendix 3X – Karen Agersborg

2018 Announcements

31.01.2018

Appendix 4C

2018 Announcements

31.01.2018

CLINUVEL appoints US based Director

2018 Announcements

29.01.2018

Chair Letter to Shareholders

2018 Announcements

10.01.2018

Preliminary recommendation by NICE not to include SCENESSE® for reimbursement by NHS England

2017 Announcements

20.12.2017

.

Go To Top